Zobrazeno 1 - 10
of 22
pro vyhledávání: '"S J, Cleland"'
Publikováno v:
The lancet. Diabetesendocrinology. 5(7)
Autor:
Ian P. Salt, Michael Small, S. J. Cleland, Naveed Sattar, G. C. Jones, Pamela J. Logan, James G. Boyle, John M. C. Connell
Publikováno v:
Diabetologia. 54:1799-1809
The hypoglycaemic actions of metformin have been proposed to be mediated by hepatic AMP-activated protein kinase (AMPK). As the effects of metformin and the role of AMPK in adipose tissue remain poorly characterised, we examined the effect of metform
Autor:
Michael Small, Mary Ann Lumsden, S. J. Cleland, J. M. C. Connell, T. Hilditch, A Kernohan, John R. Petrie, Naveed Sattar
Publikováno v:
Clinical Endocrinology. 66:27-34
Background: Low-dose hormone replacement therapy (HRT) has attracted interest for the treatment of postmenopausal symptoms in diabetes because of concerns about increased risk of coronary heart disease (CHD) and stroke with conventional HRT containin
Autor:
Roland W. McCallum, John R. Petrie, Michael Small, John M. C. Connell, O. D. McEleavy, Naveed Sattar, S. J. Cleland
Publikováno v:
Diabetic Medicine. 21:262-266
Aims To determine whether carotid-radial pulse wave velocity (crPWV), a simple non-invasive measurement of muscular artery structure and function, is increased in offspring of patients with Type 2 diabetes compared with well-matched controls with no
Publikováno v:
Diabetologia
In this review, we explore the concept of ‘double diabetes’, a combination of type 1 diabetes with features of insulin resistance and type 2 diabetes. After considering whether double diabetes is a useful concept, we discuss potential mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::953e587688ad36b7d6d38dc621ab2a51
https://eprints.gla.ac.uk/82661/2/82661.pdf
https://eprints.gla.ac.uk/82661/2/82661.pdf
Autor:
A F B, Kernohan, N, Sattar, T, Hilditch, S J, Cleland, M, Small, M A, Lumsden, J M C, Connell, J R, Petrie
Publikováno v:
Clinical endocrinology. 66(1)
Low-dose hormone replacement therapy (HRT) has attracted interest for the treatment of postmenopausal symptoms in diabetes because of concerns about increased risk of coronary heart disease (CHD) and stroke with conventional HRT containing conjugated
Publikováno v:
Diabetic Medicine. 15:S29-S31
Autor:
Jmc Connell, M. Alem, Kennedy R. Lees, Fozia S Nazir, Michael Small, Matthew Walters, S. J. Cleland
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 23(4)
Aims Diabetes is a major risk factor for stroke, but the mechanisms that impart the excess risk are unclear. Endothelial dysfunction, which has been demonstrated in the coronary and peripheral vasculature of diabetic patients, is an important early m
Autor:
Mary Ann Lumsden, Angela Spiers, Naveed Sattar, Michael Small, Chris Hillier, S. J. Cleland, John R. Petrie, Andrew Fb Kernohan, John M. C. Connell
Publikováno v:
Diabetesvascular disease research. 1(2)
Background Improvement in vascular endothelial function is widely cited as a beneficial effect of hormone replacement therapy (HRT). Women with type 2 diabetes (T2DM) are at increased cardiovascular risk and have impaired endothelial function. Any be
Circulating concentrations of C reactive protein (CRP), a hepatic derived inflammatory marker that is secreted in response to specific cytokines, have been shown to predict the risk of coronary heart disease (CHD) and diabetes in large epidemiologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c13098d961e1a1b579db91d690ffb2
https://europepmc.org/articles/PMC1768325/
https://europepmc.org/articles/PMC1768325/